Apolipoprotein B Blood Test: Normal Ranges, Causes & What Your Results Mean

What Is Apolipoprotein B?

Apolipoprotein B (ApoB) is the primary protein component of all atherogenic (artery-clogging) lipoproteins — including low-density lipoprotein (LDL), very-low-density lipoprotein (VLDL), intermediate-density lipoprotein (IDL), and lipoprotein(a). Each of these particles contains exactly one molecule of ApoB, which means that measuring ApoB gives you a direct count of the total number of atherogenic particles circulating in your blood.

This is why many lipidologists and cardiologists consider ApoB to be the single best marker of cardiovascular risk — superior to LDL cholesterol, total cholesterol, and even non-HDL cholesterol. Here is the key insight: it is the number of atherogenic particles (measured by ApoB), not the amount of cholesterol they carry (measured by LDL-C), that primarily drives atherosclerosis. Two patients with identical LDL cholesterol levels can have vastly different ApoB levels and, consequently, vastly different cardiovascular risk.

There are two main forms of apolipoprotein B: ApoB-100, which is produced by the liver and found on LDL, VLDL, and IDL particles; and ApoB-48, which is produced by the intestine and found on chylomicrons (particles that transport dietary fat). When we refer to "ApoB" in clinical practice, we almost always mean ApoB-100, as it is by far the dominant form in fasting blood samples.

Why Is Apolipoprotein B Tested?

ApoB testing is gaining recognition as a cornerstone of cardiovascular risk assessment:

• Superior cardiovascular risk prediction: Multiple large studies — including the INTERHEART study (involving 30,000 participants across 52 countries) — have demonstrated that ApoB and the ApoB/ApoA1 ratio are stronger predictors of myocardial infarction than LDL cholesterol, total cholesterol, or any other lipid measure.
• Identifying discordance: In roughly 20–30% of patients, LDL cholesterol and ApoB are discordant — meaning one is normal while the other is elevated. When ApoB is high but LDL-C is normal, the patient has a high number of small, dense LDL particles that carry less cholesterol per particle but are more atherogenic. Standard lipid panels miss this high-risk phenotype entirely.
• Monitoring statin therapy: ApoB is increasingly used to assess whether lipid-lowering therapy has adequately reduced atherogenic particle number, not just cholesterol content.
• Evaluating metabolic syndrome and diabetes: Patients with insulin resistance, type 2 diabetes, and metabolic syndrome frequently exhibit elevated ApoB with normal or near-normal LDL cholesterol. This discordant pattern — driven by an excess of small, dense LDL particles — is one reason these patients have elevated cardiovascular risk despite apparently "normal" cholesterol.
• Familial hypercholesterolaemia screening: Very high ApoB (above 1.5 g/L) raises suspicion for familial hypercholesterolaemia (FH), a genetic condition affecting 1 in 250 people in the UK that dramatically increases lifetime cardiovascular risk.
• Assessing residual risk: In patients who have achieved target LDL cholesterol on statins, persistently elevated ApoB identifies those who remain at elevated risk and may benefit from additional therapies.

Normal Apolipoprotein B Ranges

ApoB is measured in grams per litre (g/L). Targets depend on overall cardiovascular risk:

Category	ApoB Level (g/L)
Desirable (low risk)	Less than 0.90 g/L
Optimal (moderate risk)	Less than 0.80 g/L
Target for high-risk patients	Less than 0.65 g/L
Target for very high-risk patients	Less than 0.55 g/L
Elevated	Greater than 1.00 g/L
Significantly elevated	Greater than 1.20 g/L

The European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) now include ApoB targets in their 2019 dyslipidaemia guidelines, reflecting its growing importance in clinical practice.

For the ApoB/ApoA1 ratio, a value below 0.6 indicates low cardiovascular risk, while a ratio above 0.9 is considered high risk.

General reference ranges for the population:

Group	Reference Range (g/L)
Adult men	0.60–1.38 g/L
Adult women	0.52–1.29 g/L

What Do High Apolipoprotein B Levels Mean?

Elevated ApoB indicates a high number of atherogenic particles in the blood, placing you at increased risk of developing atherosclerosis, coronary heart disease, stroke, and peripheral arterial disease.

Common causes of high ApoB

• Familial hypercholesterolaemia (FH): A genetic condition causing lifelong elevated LDL and ApoB. ApoB levels often exceed 1.5 g/L. Heterozygous FH affects approximately 1 in 250 people and is dramatically underdiagnosed in the UK — an estimated 90% of cases are unidentified.
• Poor diet: High intake of saturated fat, trans fats, and refined carbohydrates raises VLDL and LDL production, increasing ApoB.
• Obesity: Particularly visceral obesity, which drives hepatic overproduction of VLDL particles.
• Type 2 diabetes and insulin resistance: Insulin resistance causes the liver to overproduce VLDL, raising ApoB. This often occurs without corresponding LDL cholesterol elevation, making ApoB measurement essential.
• Metabolic syndrome: The cluster of central obesity, insulin resistance, hypertension, and dyslipidaemia is strongly associated with elevated ApoB.
• Hypothyroidism: An underactive thyroid reduces LDL receptor activity, causing LDL and ApoB to accumulate.
• Nephrotic syndrome: Protein loss in the urine triggers compensatory hepatic lipoprotein overproduction.
• Cholestatic liver disease: Conditions that obstruct bile flow can elevate ApoB.
• Medications: Corticosteroids, thiazide diuretics, retinoids, and protease inhibitors can raise ApoB.

Why high ApoB matters

Every atherogenic particle in the blood has the potential to penetrate the artery wall, deposit its cholesterol cargo, trigger an inflammatory response, and contribute to plaque formation. The more particles (higher ApoB), the more "attempts" at artery wall infiltration per unit of time. This is the fundamental mechanism driving atherosclerosis, and it explains why ApoB is such a powerful predictor of cardiovascular events.

What Do Low Apolipoprotein B Levels Mean?

Low ApoB levels are generally favourable from a cardiovascular perspective, indicating a low burden of atherogenic particles. However, very low levels can sometimes indicate an underlying condition:

• Hyperthyroidism: An overactive thyroid increases LDL receptor activity, reducing circulating ApoB.
• Severe liver disease: The liver produces ApoB, so advanced cirrhosis or liver failure can reduce its production.
• Malnutrition: Severe calorie and protein restriction reduces lipoprotein production.
• Familial hypobetalipoproteinaemia: A rare genetic condition causing very low ApoB (typically below 0.30 g/L). Heterozygous carriers often have low LDL cholesterol and reduced cardiovascular risk.
• Abetalipoproteinaemia: An extremely rare condition where ApoB is virtually absent, causing fat malabsorption and neurological complications.
• Effective lipid-lowering therapy: Statins, ezetimibe, PCSK9 inhibitors, and bempedoic acid all reduce ApoB — which is their intended therapeutic effect.

For most people, a low ApoB is good news and no further investigation is needed.

How to Improve Your Apolipoprotein B Levels

If your ApoB is elevated, the goal is to reduce the number of atherogenic particles in your bloodstream. This is achieved through a combination of lifestyle changes and, where necessary, medication.

Dietary strategies

• Reduce saturated fat: The NHS recommends no more than 20 g/day for women and 30 g/day for men. Major sources include fatty meat, butter, cheese, cream, and baked goods.
• Eliminate trans fats: Partially hydrogenated oils (found in some processed foods) are particularly harmful. Check labels and avoid products containing them.
• Increase soluble fibre: Oats, barley, legumes, apples, and psyllium husk bind bile acids in the gut, forcing the liver to use cholesterol to make more bile — effectively reducing circulating LDL and ApoB.
• Include plant sterols and stanols: Found naturally in nuts, seeds, and vegetable oils, or added to fortified foods. Consuming 2 g/day reduces LDL by approximately 10%.
• Eat more omega-3 fatty acids: Oily fish (salmon, mackerel, sardines) at least twice a week.
• Follow a Mediterranean or portfolio diet: Both dietary patterns have robust evidence for reducing ApoB and cardiovascular risk.

Lifestyle changes

• Exercise regularly: At least 150 minutes per week of moderate-intensity activity. Exercise reduces VLDL production and improves insulin sensitivity.
• Lose excess weight: Even a 5% reduction in body weight can meaningfully reduce ApoB.
• Quit smoking: Smoking worsens the atherogenic lipid profile.
• Limit alcohol: Excessive alcohol raises triglycerides and VLDL production.

Medical treatment

• Statins: The first-line treatment. Statins reduce ApoB by 25–50% depending on the dose and specific statin. Atorvastatin and rosuvastatin are the most potent.
• Ezetimibe: Blocks intestinal cholesterol absorption. Reduces ApoB by an additional 10–15% when added to a statin.
• PCSK9 inhibitors: Alirocumab and evolocumab are injectable therapies that reduce ApoB by 40–55%. Reserved for patients at very high risk or those with FH who do not achieve targets on statins.
• Bempedoic acid: A newer oral therapy that reduces ApoB by approximately 15%. Useful for patients who cannot tolerate statins.
• Inclisiran: A twice-yearly injection that reduces ApoB by approximately 25–30%. Recently approved in the UK.

When Should You Get Tested?

Consider ApoB testing if you:

• Have a family history of premature cardiovascular disease
• Have been diagnosed with metabolic syndrome or type 2 diabetes
• Have a high triglyceride level (above 1.7 mmol/L), which makes LDL cholesterol calculations unreliable
• Are overweight or obese
• Have "normal" LDL cholesterol but other cardiovascular risk factors
• Are on statin therapy and want to assess residual risk
• Want the most accurate assessment of your cardiovascular risk

Many leading cardiologists now recommend that ApoB should be measured in all adults as part of routine cardiovascular screening, rather than relying solely on LDL cholesterol.

Which Lola Health Tests Include Apolipoprotein B?

Apolipoprotein B is available in Lola Health's advanced panels:

• Peak Insights (70 Biomarkers) — Includes ApoB, ApoA1, full lipid profile, and comprehensive cardiovascular risk markers.
• Vital Check (56 Biomarkers) — Broad health screen including advanced lipid markers.
• Heart Health Blood Test — Focused cardiovascular panel with apolipoproteins, Lp(a), and inflammatory markers.

All Lola Health tests use a venous blood draw at one of our nationwide partner clinics — never a finger prick. Results are reviewed by a doctor and returned within 4 working days.